Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial

Author(s)

• Kathinka Schmidt Slørdahl
• Katarina Puco
• Ragnhild Sørum Falk
• Ingrid Dyvik
• Sigmund Brabrand
• Pitt Niehusmann
• Eli Sihn Samdal Steinskog
• Egil Støre Blix
• Åsmund Flobak
• Irja Alida Oppedal
• Sebastian Meltzer
• Cecilie Fredvik Torkildsen
• Hanne Kristin Blakstad
• Kristina Yvonne Kathe Lindemann
• Anita Amundsen
• Sigbjørn Smeland
• Kjetil Tasken
• Åslaug Helland
• InPreD Consortium

Affiliation

• SINTEF Industry / Biotechnology and Nanomedicine
• University of Bergen
• University of Oslo
• University Hospital of North Norway
• St. Olavs Hospital, Trondheim University Hospital
• Bergen Hospital Trust - Haukeland University Hospital
• Norwegian University of Science and Technology
• Akershus University Hospital Trust
• Oslo University Hospital

DOI